HK Stock MarketDetailed Quotes

02162 KEYMED BIO-B

Watchlist
  • 48.000
  • +3.350+7.50%
Market Closed May 2 16:08 CST
13.43BMarket Cap-24.13P/E (TTM)

KEYMED BIO-B Key Stats

KEYMED BIO-B Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2026/FY-- / 1.190B--
--2025/FY-- / 673.276M--
Mar 24, 20252024/FY428.124M / 167.738M--
Mar 26, 20242023/FY354.095M / 356.052M--
Mar 17, 20232022/FY100.063M / 128.000M--
DatePeriodRevenue/EstimateEarnings Call
--2026/FY-- / 1.190B--
--2025/FY-- / 673.276M--
Mar 24, 20252024/FY428.124M / 167.738M--
Mar 26, 20242023/FY354.095M / 356.052M--
Mar 17, 20232022/FY100.063M / 128.000M--

Unlock Free Earnings Estimates

KEYMED BIO-B Earnings Reports

Read more

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve Show More